Expanding the potential of epigenetic therapies in prostate cancer
School of Medicine, Dentistry and Biomedical Sciences
- Location
- Belfast, United Kingdom
- Funding
- See university guidance
- Application deadline
- See university guidance
About the project
The work in our group focuses on the impact of altered nucleotide metabolism and epigenetics in cancer progression and the impact of standard of care therapeutics and novel agents in modulating these processes. Our aim is to contribute to the understanding on the molecular biology level and provide preclinical rational for the translation of our findings to clinical trials to improve patient care.
- Dr Melissa LaBonte Wilson: School of Medicine, Dentistry and Biomedical Sciences
Contact info
- View Academic Profile
- askmhls@qub.ac.uk
- +44 (0)28 9097 2789
Research Interests
Open to PhD applications in the field of
Make a PhD enquiry
- Investigate key processes involved in the underlying biology driving epigenetic alterations
- Nucleotide metabolism in cancer development
- Novel drug targeting of these processes through in vitro cell line-based models and in vivo cancer mouse models.
Research students
PhD Title | Expanding the potential of epigenetic therapies in prostate cancer
Country | UK
Discover More
- Faculty of Medicine, Health and Life Sciences
- School of Medicine, Dentistry and Biomedical Sciences